A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of ...

After first finding multiple tumors on her brain in February, the reality show star finally had some positive news to share ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

Among patients with non-muscle-invasive bladder cancer (NMIBC), neoadjuvant treatment with mitomycin C prior to transurethral ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

A simple blood test could reveal who is at high risk of skin cancer recurrence after tumor-removal surgery.The test can ...

Melanoma is a less common form of skin cancer that is more dangerous ... examined the levels of circulating tumor DNA (ctDNA) found in cancer patients' blood. Approximately 80% of stage 3 melanoma ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

The study, published in the Journal of Clinical Investigation, reveals that pyrvinium pamoate—a drug approved in the 1950s to ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...